Wall Street Has a Positive Outlook on ​MetLife, Inc. (MET)

​MetLife, Inc. (NYSE:MET) is one of the Best Very Cheap Stocks to Invest In. Wall Street has a positive outlook on MetLife, Inc. (NYSE:MET) despite mixed results for fiscal Q3 2025. On November 11, Ryan Krueger from KBW lowered the price target on the stock from $92 to $90 and maintained a Buy rating. Earlier on November 7, Elyse Greenspan from Wells Fargo had also reiterated a Buy rating on the stock, but lowered the price target from $96 to $92.

​The positive outlook follows the company’s fiscal Q3 2025 results, announced on November 5. The revenue decreased by 5.85% year-over-year to $17.36 billion, and fell short of the expectations by $789.2 million. On the bright side, the EPS of $2.37 topped estimates by $0.05.

Management attributed revenue loss to a large net investment loss of $325 million and a net derivative loss of $929 million. Despite this loss, the company was still able to increase its adjusted earnings per share by 21%, driven by strong variable investment income, broad-based volume growth, and diligent expense management.

​MetLife, Inc. (NYSE:MET) is a global financial services company that provides insurance, annuities, employee benefits, and asset management services to individual and institutional customers.

While we acknowledge the potential of MET as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.